🔎 Trials Near Me

Home › Medulloblastoma › Pennsylvania › Philadelphia

Medulloblastoma clinical trials in Philadelphia, PA

4 studies for Medulloblastoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

RecruitingPhase 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi away
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RecruitingPhase 2
  • Children's Hospital of Philadelphia, Philadelphia
Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Recruiting
  • Children's Hospital of Philadelphia, Philadelphia
12 Months – 39 Years · All sexes · Updated Aug 11, 2026 · NCT05057702

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

RecruitingPhase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Ages 4 to 39 · All sexes · Updated Jul 20, 2026 · NCT05278208

Medulloblastoma trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.